RECURSION PHARMACEUTICALS, INC.

Profile

Company Names

RECURSION PHARMACEUTICALS, INC.
RECURSION PHARMACEUTICALS, LLC

Addresses

41S RIO GRANDE STREET, SALT LAKE CITY, UT 84101

630 S. KOMAS DRIVE, SUITE 300, SALT LAKE CITY, UT 84108

383 S. COLOROW DR, SALT LAKE CITY, UT 84108

Phone Numbers

(385) 269-0203
801-587-1629

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$474,349,296.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2020-09-01 
$245,896,677.00 
$245,896,677.00 
$0.00 
Equity 
7
2019-02-12 
$122,057,689.00 
$122,057,689.00 
$0.00 
Equity 
6
2017-09-25 
$55,799,946.00 
$59,999,975.00 
$4,200,029.00 
Equity 
5
2016-09-02 
$15,034,984.00 
$15,034,984.00 
$0.00 
Equity 
4
2016-09-01 
$32,000,000.00 
$32,000,000.00 
$0.00 
Equity 
3
2015-11-20 
$2,650,000.00 
$2,700,000.00 
$50,000.00 
Debt 
2
2015-02-17 
$830,000.00 
$1,000,000.00 
$170,000.00 
Debt 
1
2014-03-19 
$80,000.00 
$200,000.00 
$120,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BLAKE 
 
BORGESON 
EXECUTIVE OFFICER, DIRECTOR
BLAKE 
C. 
BORGESON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TERRY-ANN 
 
BURRELL 
DIRECTOR
H. 
PERRY 
FELL 
DIRECTOR
CHRISTOPHER 
 
GIBSON 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
GIBSON 
EXECUTIVE OFFICER
CHRISTOPHER 
C. 
GIBSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DEAN 
 
LI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DEAN 
Y. 
LI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JOHN 
 
PEREIRA 
EXECUTIVE OFFICER
MICHAEL 
 
SECORA 
EXECUTIVE OFFICER, PROMOTER
DEAN 
Y. 
YI 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-12 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-25 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-01 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2015-11-20 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2015-02-17 
D/A
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2014-03-19 
D
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2014-03-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ALLEN + COMPANY